PW MEDTECH GROUP DL-0001 (PWE) — Capital Reinvestment Ratio
Latest as of December 2025:
0.44x
PW MEDTECH GROUP DL-0001 (PWE) has a Capital Reinvestment Ratio of 0.44x as of December 2025, meaning it reinvests 0% of its operating cash flow (€240.70 Million) in capital expenditures (€105.05 Million). See PW MEDTECH GROUP DL-0001 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.44x
Capex / Operating Cash Flow
Operating Cash Flow
€240.70 Million
EUR
Capital Expenditures
€105.05 Million
EUR
Data as of
Dec 2025
Most recent filing
PW MEDTECH GROUP DL-0001 Capital Reinvestment Ratio (2021–2025)
This chart tracks PW MEDTECH GROUP DL-0001's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for PW MEDTECH GROUP DL-0001 (2021–2025)
Year-by-year Capital Reinvestment Ratio for PW MEDTECH GROUP DL-0001 from 2021 to 2025. For live market cap and broader valuation context, see PWE company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | €240.70 Million | €105.05 Million | ▲ +92.8% |
| 2024 | 0.23x | €318.43 Million | €72.08 Million | ▼ -41.7% |
| 2023 | 0.39x | €211.03 Million | €81.91 Million | ▲ +68.9% |
| 2022 | 0.23x | €269.23 Million | €61.86 Million | ▼ -24.4% |
| 2021 | 0.30x | €37.24 Million | €11.32 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow